Prevention of Atrial Fibrillation by Optimized Overdrive Stimulation
NCT ID: NCT01912326
Last Updated: 2024-10-08
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
249 participants
INTERVENTIONAL
2002-07-31
2008-04-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Hypothesis:
Dynamic atrial Overdrive (AF Suppression) reduces AT/AF Burden by 30% as compared to programming DDDR-(60) without AF Suppression when all other parameters are optimized.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Device-based Rate Versus Rhythm Control in Symptomatic Recent-onset Atrial Fibrillation (RACE 9 OBSERVE-AF)
NCT04612335
AV-node Stimulation Clinical Download Study to Reduce Ventricular Rate During AF
NCT01095952
Impact of Pacing Mode and Diastolic Function on Cardiac Output
NCT04068233
Substrate Modification in Stable Ventricular Tachycardia in Addition to Implantable Cardioverter Defibrillator (ICD) Therapy
NCT00919373
Cardioneural Temporary Pacing to Achieve Autonomic Modulation
NCT07247422
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
PREVENTION
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
AF Suppression On
AF Suppression Algorithm On, optimized AF Pacemaker Programming
Pacemaker Implantation
Implantation of a dual chamber pacemaker
AF Suppression Off
AF Suppression programmed Off, Optimized Pacemaker Programming
Pacemaker Implantation
Implantation of a dual chamber pacemaker
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Pacemaker Implantation
Implantation of a dual chamber pacemaker
Other Intervention Names
Discover alternative or legacy names that may be used to describe the listed interventions across different sources.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* documented paroxysmal or persistent Atrial Fibrillation
* P-wave \>1.0 mV in Sinus Rhythm or sufficient detection of AFib
* stable antyarrhythmic therapy
* age \>= 19 years
* written informed consent
* implantation of a Identity DR 5370/5376 or later
* bipolar atrial lead
Exclusion Criteria
* reversible etiology of AFib
* HYHA II or IV
* Coronary Artery disease with stable angina pectoris
* implanted ICD or planned implantation of a ICD
* cardiac surgery within the last 6 months or planned within 12 months
* live expectancy \< 12 months
* pregnancy
19 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Abbott Medical Devices
INDUSTRY
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Universitätsklinikum Bonn AdöR
Bonn, , Germany
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
B01- 408
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.